COM:TEVOGEN
Tevogen Bio
- Stock
Last Close
1.64
22/11 17:09
Market Cap
288.83M
Beta: -
Volume Today
1.43M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '21 | Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -17.33K - | -25.99K 49.95% | 207.00K 896.51% | 1.61M 679.17% | 2.61M 62.10% | -30.76M 1,276.37% | -22.18M 27.87% | -278.75K 98.74% | -828.92K 197.38% | 11.26M 1,458.97% | 6 100.00% | |
depreciation and amortization | 91.21K - | -11.74K 112.87% | 98.30K - | |||||||||
deferred income tax | ||||||||||||
stock based compensation | 26.33M - | |||||||||||
change in working capital | -533.33K - | 169.84K 131.85% | 212.69K 25.22% | 156.23K 26.54% | 198.93K 27.33% | 55.80K 71.95% | -125.87K 325.56% | 397.51K 415.82% | -46.20K 111.62% | 517.84K 1,220.76% | ||
accounts receivables | ||||||||||||
inventory | ||||||||||||
accounts payables | 38.45K - | 89.63K 133.12% | -29.63K 133.05% | 72.41K 344.42% | 38.67K 46.59% | 497.48K 1,186.45% | -124.87K 125.10% | 306.12K 345.15% | 141.37K 53.82% | 1.70M 1,100.65% | ||
other working capital | -571.78K - | 80.22K 114.03% | 242.31K 202.06% | 83.82K 65.41% | 160.25K 91.18% | 142.39K 11.15% | -80.54K 156.56% | 91.39K 213.48% | -187.57K 305.25% | -1.18M 528.83% | ||
other non cash items | -201.61K - | -346.52K 71.88% | -435.96K 25.81% | -1.88M 332.18% | -2.87M 52.11% | 28.43M 1,092.06% | 20.10M 29.29% | -633.34K 103.15% | 40.05K 106.32% | -40.41M 101,006.51% | ||
net cash provided by operating activities | -713.83K - | -113.03K 84.16% | -45.90K 59.39% | -42.60K 7.19% | -13.86K 67.46% | -2.18M 15,606.91% | -2.22M 1.85% | -208.46K 90.60% | -693.71K 232.77% | -2.16M 211.92% | ||
investments in property plant and equipment | -133K - | |||||||||||
acquisitions net | ||||||||||||
purchases of investments | -351.90M - | -67.50K - | ||||||||||
sales maturities of investments | 333.27M - | 9.71M - | ||||||||||
other investing activites | ||||||||||||
net cash used for investing activites | -351.90M - | -133K - | 9.65M - | |||||||||
debt repayment | -2.50M - | -901K 63.96% | -422.50K - | |||||||||
common stock issued | 352.96M - | -333.27M - | 333.27M - | 2M - | ||||||||
common stock repurchased | -333.27M - | -9.71M 97.09% | ||||||||||
dividends paid | ||||||||||||
other financing activites | 229.33K - | |||||||||||
net cash used provided by financing activities | 352.96M - | 2.50M - | 901K 63.96% | -9.29M - | 2.43M 126.15% | |||||||
effect of forex changes on cash | ||||||||||||
net change in cash | 344.58K - | -113.03K 132.80% | -45.90K 59.39% | -42.60K 7.20% | -13.86K 67.46% | 189.87K 1,469.78% | -2.22M 1,267.95% | -208.46K 90.60% | -338.71K 62.48% | 265.50K 178.39% | ||
cash at beginning of period | 1 - | 344.58K 34,458,000% | 231.55K 32.80% | 185.65K 19.82% | 143.05K 22.95% | 5.48M 3,733.89% | 5.67M 3.46% | 556.01K 90.20% | 347.55K 37.49% | 1.05M 202.81% | ||
cash at end of period | 344.58K - | 231.55K 32.80% | 185.65K 19.82% | 143.05K 22.95% | 129.19K 9.69% | 5.67M 4,292.22% | 3.46M 39.08% | 347.55K 89.95% | 8.84K 97.46% | 1.32M 14,816.81% | ||
operating cash flow | -713.83K - | -113.03K 84.16% | -45.90K 59.39% | -42.60K 7.19% | -13.86K 67.46% | -2.18M 15,606.91% | -2.22M 1.85% | -208.46K 90.60% | -693.71K 232.77% | -2.16M 211.92% | ||
capital expenditure | -133K - | |||||||||||
free cash flow | -713.83K - | -113.03K 84.16% | -45.90K 59.39% | -42.60K 7.19% | -13.86K 67.46% | -2.31M 16,566.44% | -2.22M 4.01% | -208.46K 90.60% | -693.71K 232.77% | -2.16M 211.92% |
All numbers in (except ratios and percentages)